Board of Directors

Ray Monteleone

Ray Monteleone

Ray Monteleone brings more than 50 years of experience in corporate strategic planning, mergers and acquisitions, and tax and financial planning to the H-CYTE board.

Monteleone is an owner of Paladin Global Partners LLC, Dannelly Monteleone & Associates LLC and Monteleone & Associates Consulting, LLC based in Ft. Lauderdale, Florida. He is a former partner at Arthur Young & Co. (which later became Ernst & Young), and a former deputy commissioner and chief operating officer with the Florida Department of Education (FLDOE).

Monteleone graduated cum laude from the New York Institute of Technology and earned an MBA from Florida Atlantic University. He also completed the Arthur Young Harvard Business School program. 

Considered an expert in financial analysis and business management, Monteleone is regularly featured as a lecturer at various universities and professional associations.

Richard Rosenblum

Richard Rosenblum

Richard Rosenblum is a business veteran and entrepreneur in the areas of the financial services, capital markets, healthcare, technology and real estate. He brings years of experience to the H-CYTE board, ranging from serving as managing director at several investment merchant banks to heading companies as a C-suite executive. He also sits on the boards of public and private healthcare, life sciences and technology-sector companies.

Rosenblum is currently President, CFO and Board Member of Innovative Payment Solutions, Inc., a California-based FinTech company focused on building a 21st century universal digital payment and money remittance platform. As the founder of Harborview Capital Advisors, LLC, Rosenblum leads a team of strategic advisors in the areas of capital formation, merchant banking and management consulting, and has raised more than $250 million in capital funding for companies. Since founding it over 20 years ago, Rosenblum has served as manager and director of Harborview Property Management LLC, raising over $100 million while managing domestic and international commercial and multi-family real estate assets. From 2008 to 2014, Rosenblum was Director, President and Executive Chairman of Alliqua Biomedical Inc. (NASDAQ: ALQA), a leader in hydrogel manufacturing technology in the wound care sector.

Rosenblum received his B.A. in Finance & Accounting from the State University of New York at Buffalo in 1981, graduating summa cum laude.

Michael Yurkowsky

Michael Yurkowsky

Michael Yurkowsky brings more than 25 years of experience in financial services to the H-CYTE Board. He currently serves as President and Chairman of Deverra Therapeutics, a clinical stage biotech developing allogeneic cell therapies.

Yurkowsky spent his early career working as a broker with several national broker-dealers and as a licensed investment banker. He went on to start and manage his own hedge fund, specializing in debt arbitrage. In 2012, he opened his own family office, YP Holdings LLC, which has invested in more than 50 private companies and participated in more than 100 public company financing transactions.

Throughout his career, Mr. Yurkowsky has served on multiple public and private boards and has been involved in several M&A transactions.

Matthew Anderer

Matthew Anderer

Matthew Anderer brings extensive experience to the H-CYTE board, beginning his career in the United States Air Force as a fast jet and special operations pilot and instructor before taking operational and staff officer roles with Special Operations Command and NATO. He has commanded worldwide airlift capability of the highest posts within the White House and from a technology perspective, he has directed a range of high-profile, high-value acquisition projects. Anderer was the Director of the US Air Force leadership and citizenship development program for 220,000 cadets before taking command of the busiest air mobility group in the world, responsible for support to destinations world-wide. Among other contingency crisis operations in this capacity, Matt played a crucial role establishing robust, resilient, and repeatable processes to prevent the potential spread of the Ebola Virus for aircraft, cargo and passengers that transited sub-Saharan West Africa. He is currently the training systems Country Integration Lead for Lockheed Martin’s F-35 International customers, a position that he has held since prior to 2017.

Most recently, Anderer was also a member of the Board for Deverra Therapeutics, a clinical stage cell therapy company headquartered in Seattle. He is a graduate of Villanova University, Air Command and Staff College, Naval Staff College and the Geneva Center for Security Policy.

William E. Horne

William E. Horne

Bill Horne brings years of entrepreneurial and business development accomplishments to the H-CYTE board, with C-suite roles in several of the fastest growing health care and hospitality organizations across the country. He has expertise in the areas of corporate planning, executive leadership and business operations strategy.

Bill served as CEO of H-CYTE from 2018 to 2020. Prior to that he was CEO of Laser Spine Institute, driving annual revenues as high as $288 million during his leadership. Bill has also served as CEO and Chairman of Outback Sports, and CEO and Chairman of Club Operations and Property Management.